David J Clark - Net Worth and Insider Trading
David J Clark Net Worth
The estimated net worth of David J Clark is at least $67,221 dollars as of 2024-05-10. David J Clark is the Chief Medical Officer of Aldeyra Therapeutics Inc and owns about 17,878 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $67,221. Details can be seen in David J Clark's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David J Clark has not made any transactions after 2019-09-06 and currently still holds the listed stock(s).
Transaction Summary of David J Clark
David J Clark Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David J Clark owns 2 companies in total, including Aldeyra Therapeutics Inc (ALDX) , and Trevi Therapeutics Inc (TRVI) .
Click here to see the complete history of David J Clark’s form 4 insider trades.
Insider Ownership Summary of David J Clark
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-06 | Chief Medical Officer |
| TRVI | Trevi Therapeutics Inc | 2022-11-14 | Chief Medical Officer |
David J Clark Latest Holdings Summary
David J Clark currently owns a total of 1 stock. David J Clark owns 17,878 shares of Aldeyra Therapeutics Inc (ALDX) as of September 6, 2019, with a value of $67,221.
Latest Holdings of David J Clark
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-06 | 17,878 | 3.76 | 67,221 |
Holding Weightings of David J Clark
David J Clark Form 4 Trading Tracker
According to the SEC Form 4 filings, David J Clark has made a total of 1 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 5,000 shares on September 6, 2019, which cost David J Clark around $25,300.
Insider Trading History of David J Clark
- 1
David J Clark Trading Performance
GuruFocus tracks the stock performance after each of David J Clark's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David J Clark is -4.06%. GuruFocus also compares David J Clark's trading performance to market benchmark return within the same time period. The performance of stocks bought by David J Clark within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David J Clark's insider trading performs compared to the benchmark.
Performance of David J Clark
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.4 | | | | | |
| Relative Return to S&P 500(%) | 15.3 | | | | | |
David J Clark Ownership Network
David J Clark Owned Company Details
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
David J Clark is the Chief Medical Officer of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include 10 percent owner Perceptive Life Sciences Master Fund Ltd , Chief Development Officer Stephen Machatha , and director & President and CEO Todd C Brady .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, David J Clark made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 41,305 shares made by Stephen Machatha , and a net sale of 26,402 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 250,945 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 682,265 shares, with a net purchase of 431,320 shares. During the past 18 months, 3,007,444 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,325,179 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
David J Clark Mailing Address
Above is the net worth, insider trading, and ownership report for David J Clark. You might contact David J Clark via mailing address: 131 Hartwell Ave, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
